3/5 HEAL Consortium: Establishing Innovative Approaches for the HEALthy Brain and Child Development Study

新冠肺炎疫情影响了儿童及其家长的身心健康。这个 大流行还影响了美国大多数机构进行面对面研究的能力 各州。然而，最近的技术进步可能会使许多面对面的评估过渡到虚拟 格式。迫切需要开发当前使用的家庭评估的虚拟版本 环境和亲子互动，并同时研究新冠肺炎大流行对 家庭关系。拟议的项目旨在通过在正在进行的基础上，解决这一紧迫需求 NIH健康大脑和认知发展(HBCD)研究的三个站点之间的研究成果： 阿肯色州儿童研究所、辛辛那提儿童医院和北卡罗来纳大学 教堂山。我们将在90名有婴儿的照顾者中开发和测试虚拟版本的家庭清单 年龄在6-18个月之间。我们将通过执行面对面的房屋清点来验证此虚拟版本 对其中45个二元组进行了评估。在所有参与者中，我们将使用标准问卷来评估CoVID- 19暴露和影响。最后，我们将研究区域和时间变化之间的关联 新冠肺炎的暴露和影响以及家居库存的维度。这项研究的结果将用于 为了完成可在未来研究中广泛使用的虚拟房屋清单协议的开发， 包括HBCD第二阶段研究。

The COVID-19 pandemic has affected the mental and physical health of children and their parents. The pandemic has also affected the ability to conduct in-person research at most institutions across the United States. However, recent technological advances may allow many in-person assessments to transition to virtual formats. There is an urgent need to develop virtual versions of currently used assessments of the home environment and parent-child interactions, and to concurrently study the effect of the COVID-19 pandemic on family relationships. The proposed project seeks to address this urgent need by building upon ongoing research efforts among three sites from the NIH HEALthy Brains and Cognitive Development (HBCD) study: Arkansas Children’s Research Institute, Cincinnati Children’s Hospital, and the University of North Carolina at Chapel Hill. We will develop and test a virtual version of the HOME Inventory in 90 caregivers with infants between 6-18 months of age. We will validate this virtual version by performing in-person HOME Inventory assessments in 45 of these dyads. In all participants, we will use a standard questionnaire to assess COVID- 19 exposure and impact. Finally, we will examine associations between regional and temporal variations in COVID-19 exposure and impact and dimensions of the HOME Inventory. The results of this study will be used to finalize the development of a virtual HOME Inventory protocol that can be widely used in future studies, including the HBCD Phase II study.